Kyntra Bio, Inc. (KYNB)
8.02
+0.02
(+0.25%)
USD |
NASDAQ |
Aug 28, 16:00
7.975
-0.04
(-0.56%)
After-Hours: 20:00
Kyntra Bio Profit Margin (Quarterly) : -812.3% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -812.3% |
| March 31, 2026 | -404.8% |
| December 31, 2025 | -1.14K% |
| September 30, 2025 | -1.22K% |
| June 30, 2025 | -1.02K% |
| March 31, 2025 | -612.1% |
| December 31, 2024 | -276.3% |
| September 30, 2024 | -39.26K% |
| June 30, 2024 | -4.72K% |
| March 31, 2024 | -193.4% |
| December 31, 2023 | -1.72K% |
| September 30, 2023 | -158.5% |
| June 30, 2023 | -197.8% |
| March 31, 2023 | -212.1% |
| December 31, 2022 | -192.6% |
| September 30, 2022 | -582.5% |
| June 30, 2022 | -243.7% |
| March 31, 2022 | -103.9% |
| December 31, 2021 | -810.5% |
| September 30, 2021 | 31.93% |
| June 30, 2021 | -549.9% |
| March 31, 2021 | -186.7% |
| December 31, 2020 | -90.21% |
| September 30, 2020 | 74.95% |
| June 30, 2020 | -198.9% |
| Date | Value |
|---|---|
| March 31, 2020 | -321.1% |
| December 31, 2019 | -1.23K% |
| September 30, 2019 | -149.0% |
| June 30, 2019 | 60.56% |
| March 31, 2019 | -190.3% |
| December 31, 2018 | 19.39% |
| September 30, 2018 | -146.6% |
| June 30, 2018 | -53.29% |
| March 31, 2018 | -129.7% |
| December 31, 2017 | -110.3% |
| September 30, 2017 | -60.32% |
| June 30, 2017 | -105.4% |
| March 31, 2017 | -104.0% |
| December 31, 2016 | -106.5% |
| September 30, 2016 | -80.24% |
| June 30, 2016 | 27.24% |
| March 31, 2016 | -98.44% |
| December 31, 2015 | -210.2% |
| September 30, 2015 | -230.8% |
| June 30, 2015 | 47.33% |
| March 31, 2015 | -284.5% |
| December 31, 2014 | -313.9% |
| September 30, 2014 | -289.4% |
| June 30, 2014 | 52.06% |
| March 31, 2014 | -90.85% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vericel Corp. | 2.85% |
| Capricor Therapeutics, Inc. | -- |
| ARS Pharmaceuticals, Inc. | -185.2% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -23.95% |
| Return on Net Operating Assets | -533.1% |